Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Schoppmeyer, Konrad ^a   Weis, Sebastian ^a   Mössner, Joachim ^a   Fleig, Wolfgang E ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL;

ANGIOGRAPHY; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CRYOABLATION; DATA ANALYSIS; DRUG EFFECT; ECHOGRAPHY; FOLLOW UP; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LASER COAGULATION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 70049090413     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006745.pub2     Document Type: Review

References (58)

1. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, et al.Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Annals of Surgery 2005;242(1):36-42.
2. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. Scandinavian Journal of Gastroenterology 2003;38(7):770-778
3. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cmor less. Gut 2005; 54(8):1151-1156 (Pubitemid 41025911)
4. Ohnishi K. Comparision of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepato-Gastroenterology 1998;45:1254-1258 (Pubitemid 28372109)
5. * Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27(1):67-72.
6. Bottelli R, Iamoni G, Gelosa F, Caspani B, Cecconi P, Zavaglia C, et al.Interstitial laser photocoagulation (ILP) vs percutaneous ethanol injection (PEI) for treatment of hepatocellular carcinoma (HCC): preliminary results of a randomized pilot study [EASL abstract]. Journal of Hepatology 1997;26:S141.
7. Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MC, et al.Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998;27(6): 1578-1583 (Pubitemid 28264682)
8. Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B, et al.Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with nonresectable hepatocellular carcinoma. World Journal of Gastroenterology 2006;12(23):3707-3715 (Pubitemid 43950948)
9. Huo TL, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scandinavian Journal of Gastroenterology 2002;37(3):350-355 (Pubitemid 34194823)
10. Huo T, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, et al.Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. Alimentary Pharmacology and Therapeutics 2004;19(12):1301-1308 (Pubitemid 38859507)
11. Orlando A, Cottone M, Virdone R, Parisi P, Sciarrino E, Maringhini A, et al.Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection: A trial with a comparison group. Scandinavian Journal of Gastroenterology 1997;32(6):598-603. (Pubitemid 27314272)
12. Sarin SK, Sreenivas DV, Saraya A, Mehta S, Lahoti D, Malhotra V. Improved survival with percutaneous ethanol injection in patients with large hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 1994;6(11):999-1004. (Pubitemid 24322869)
13. Tsai WL, Cheng JS, Lai KH, Lin CP, Lo GH, Hsu PI, Yu HC, Lin CK, Chan HH, Chen WC, Chen TA, Li WL, Liang HL. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - a long-term follow-up study. Aliment Pharmacol Ther. 2008 Aug 1;28(3):304-311
14. Abrishami A, Nasseri-Moghaddam S, Eghtesad B, Sherman M. Surgical resection for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006935]
15. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al.Results of surgical and nonsurgical treatment for hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-1229
16. Awad T, Thorlund K, Gluud C. Cryotherapy for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007611]
17. Begg CB, Mazumar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088-1101
18. Bismuth H, Majno PE. Hepatobiliary surgery. Journal of Hepatology 2000;32:208-224
19. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-S16. (Pubitemid 39423365)
20. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al.Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology 2001;35:421-430 (Pubitemid 32844200)
21. Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al.Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scandinavian Journal of Gastroenterology 2008;43(6):717-735 (Pubitemid 351868714)
22. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality of cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 2003;348: 1625-1638 (Pubitemid 36459468)
23. Coleman MP, Gatta G, Verdeccia A, Esteve J, Sant M, Storm H, et al.EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Annals of Oncology 2003;14(Suppl 5):V128-V149. (Pubitemid 46417466)
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalyses detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-634 (Pubitemid 27387172)
25. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. New England Journal of Medicine 1999; 340:745-750 (Pubitemid 29114292)
26. El-Serag H. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-S34. (Pubitemid 39423367)
27. El Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-468 (Pubitemid 38182303)
28. Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003046.pub2]
29. Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2009, Issue 2. Art. No.: LIVER.
30. Heffernan N, Webster K, Odom L, Martone M, Passik S, Bookbinder M, et al.Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy - hepatobiliary questionnaire. Journal of Clinical Oncology 2002; 20(9):2229-2239 (Pubitemid 34441650)
31. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 2002;21:1539-1558
32. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Colloboration, 2008. Available from www.cochranehandbook.org.
33. International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1997.
34. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials inmetaanalyses. Annals of Internal Medicine 2001;135(11):982-989 (Pubitemid 33131619)
35. Lencioni R, Pinto F, Bassi AM, Moretti M, Di Giulio M, Marchi S, et al.Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: an European experience. European Radiology 1997;7:514-519 (Pubitemid 127538668)
36. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al.Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228(1):235-240 (Pubitemid 36736097)
37. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004;127(6):1714-1723 (Pubitemid 39575850)
38. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolodi L, et al.Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197(1): 101-108
39. Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, et al.Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 2000;31:54-58 (Pubitemid 30033689)
40. Mackaskill P, Walter SD, Irwing L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001; 20:641-654 (Pubitemid 32166424)
41. Machin D, Stenning SP, Parmar MK, Fayers PM, Girling DJ, Stephens RJ, et al.Thirty years of Medical Research Council randomized trials in solid tumours. Clinical Oncology 1997;9:100-114 (Pubitemid 27198978)
42. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine 1996;334:693-699 (Pubitemid 26079803)
43. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352 (9128):609-613 (Pubitemid 28380142)
44. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996;24:1379-1385 (Pubitemid 26399034)
45. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72. (Pubitemid 28041536)
46. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the World Cancer Burden: GLOBOCAN 2000. International Journal of Cancer 2001; 94:153-156
47. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005;55(2):74-108.
48. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-2834 (Pubitemid 28562978)
49. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
50. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al.SEER cancer statistics. http://seer.cancer.gov/csr/1975-2001/ (accessed 14 May 2007).
51. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003; 19(4):591-603. (Pubitemid 38405633)
52. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-412
53. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al.A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129(1):122-130 (Pubitemid 41002049)
54. Sørensen HT, Mellemkjær L, Jepsen P, Thulstrup AM, Baron J, Olsen JH, et al.Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. Journal of Clinical Gastroeterology 2003;36: 356-359 (Pubitemid 36331620)
55. Takamori R, Wong LL, Dang C, Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary?. Liver Transplantation 2000;6:67-72. (Pubitemid 30123370)
56. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-605
57. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, et al.Treatment strategy for small heptocellular carinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-713 (Pubitemid 32927994)
58. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transplantation 2002;8(9):765-774 (Pubitemid 35012284)